Like You've Never Seen
 

Never Wait for a Diagnosis Again.

Real-time Biopsy Quality Assessment with Bioptic™

 
slide for website - adjusted.png
 
michael-longmire-L9EV3OogLh0-unsplash.jpg

Patients

On average, 20-25% of all biopsies are inadequate for diagnosis due to lack of on-site quality assessment. Patients are frequently readmitted, re-biopsied, and endure weeks of intermediary stress.

Pathologists

The average pathologist has a billing potential of $638 per hour, due mostly to work performed in the pathology lab. While performing on-site evaluation, pathologists bill at a mere $88 per hour — just 14% of the national average.

jc-gellidon-Ks5m44_nmVs-unsplash.jpg

Hospitals

There are 2.7M fine-needle aspirated biopsies collected each year; each procedure has direct costs of $3,000 per procedure. The aggregate cost of repeat procedures and unnecessary surgeries amounts to $1.6B annually.

INSURANCE

Of all Thyroid surgeries (i.e., a thyroidectomy) following an indeterminate biopsy, 92% are later found to be unnecessary. At $11,000 per surgery, stand to lose $165M annually on these unwarranted procedures.

 

Collaborators:

banner 7 bnw.jpg